Good MorningThe S&P 500 held steady on Tuesday. The market is awaiting today’s expected tariff announcement and appears poised to move once the news breaks. The question is whether the tariffs are as bad as the market feared or worse. If only as bad as feared, there is a chance the index could begin to rebound on the news. As it is, the S&P 500 is down about 10% from its peaks.
Labor market data is the other market-moving news this week. The data is expected to show resilient conditions that otherwise suggest economic health. The risk for the market is twofold. If the data is hot, it will raise fears of inflation, high interest rates, and a potential recession, while weak data will point to a recession.
The narrative may begin to change as soon as next week. The first significant earnings reports of the Q1 reporting cycle are due and will set the tone for the season. Featured: $500 to “Partner” with Elon Musk? Shocking… (Brownstone Research) 
|
Markets | | | The trade war that U.S. President Donald Trump has escalated in his second term is a challenge for all Asian economies, large and small, in an era when the most populous region of the world is expected to drive global economic growth.Export manufacturing and free trade helped transform China and oth... Read the Full Story |
|
From Our PartnersThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. | | | | Click here to check out my full write-up. |
|
Markets | | | President Donald Trump announced far-reaching new tariffs on nearly all U.S. trading partners — a 34% tax on imports from China and 20% on the European Union, among others — that threaten to dismantle much of the architecture of the global economy and trigger broader trade wars.Trump, in a Rose Gard... Read the Full Story |
|
Markets | | | U.S. stocks whipped through another dizzying day of trading, but the mood on Wall Street turned sour after President Donald Trump unveiled sweeping new tariffs against nearly all U.S. trading partners, an action that could drastically remake the global economy Read the Full Story |
|
From Our PartnersDoctors are human. They can be overworked and tired which causes them to overlook critical information. That's where AI comes in. This company is developing groundbreaking AI technology to assist doctors. In an industry estimated to grow to $187 billion by 2030, imagine the growth potential! | | | | Don't miss out-see what makes this AI stock stand out. |
|
Markets | | | Asian shares were mostly falling Wednesday, shaken by jitters over what President Donald Trump will announce about tariffs on what he referred to as “Liberation Day."Japan's benchmark Nikkei 225 recouped early losses and was down less than 0.1%, at 35,618.04 in morning trading. Australia's S&P/... Read the Full Story |
|
Markets | | |
Occidental Petroleum Co. (NYSE: OXY) stock and Warrant Buffett are often used in the same sentence these days. Even as Warren Buffett has raised his cash holdings in Berkshire Hathaway Inc. (NYSE: BRK.A) (NYSE: BRK.B), Occidental was one of the few stocks he has upped his stakes in.
As Occident... Read the Full Story |
|
From Our PartnersHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next.
But here's the truth… This is just the beginning.
Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better.
Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times.
Don't wait for the next crash to wipe you out. Act now. | | | | Get Your FREE Presidential Transition Guide Today |
|
Markets | | |
Amazon.com Inc. (NASDAQ: AMZN) is back in the spotlight after falling to fresh 2025 lows during Monday's session. The stock, now down more than 20% from its all-time high in February, is officially in a technical bear market. This latest drop is particularly notable because it has brought shares... Read the Full Story |
|
Markets | | | Rusting pipes in a barren field and unpaid workers are what remain after a U.S. company promised to turn a huge piece of land in Senegal — about twice the size of Paris — into an agricultural project and create thousands of jobs Read the Full Story |
|
Markets | | |
Salesforce (NYSE: CRM) is among the most resilient software stocks for reductions in business spending and the market downturns they cause, at least in the eyes of analysts at Evercore ISI. They believe the company’s AI offering and breadth set it apart from competitors, and that moat is r... Read the Full Story |
|
Markets | | |
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) is trading down 5.19%, and the NASDAQ 100, as tracked by the Invesco QQQ (NASDAQ: QQQ), is down 8.2% year-to-date (YTD) as of March 28, 2025. The markets attempted a relief rally that was rejected at the 200-day moving average on the SPY. A number o... Read the Full Story |
|
Markets | | |
Investors may see a disconnect between the headlines that D-Wave Quantum Inc. (NYSE: QBTS) has generated and its share price performance in recent weeks. The quantum computing firm came out with two seemingly significant technological updates so far in 2025—first, a report that it had a... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California. | | View Today's Stock Pick |
|
